This technology is a fully integrated holographic microscope system capable of simultaneous, high-resolution imaging and precise stimulation of 3D neuronal circuits using optogenetics.

This technology is an automated screening algorithm that analyzes patterns in verbal communication for early stage diagnosis of Alzheimer’s disease and related cognitive impairments.

This technology is an in vitro platform for assessing the role of epigenetic changes in neuropsychiatric diseases.

This technology is an approach to simultaneously track donor-acceptor-tagged proteins or pairs of proteins and observe their FRET signal during diffusion at the plasma membrane, thereby linking protein structural dynamics and protein-protein interactions to their movement at the cell membrane.

This technology is a programmable peptide microarray platform capable of identifying immunoreactive epitopes for high-specificity serodiagnosis of hemorrhagic fever viruses, including Ebola virus.

This technology is a tissue culture method with controllable mimicry and patterning of the four phases of human skin wound healing (pre-injury skin, injured skin with stress-response, healing skin, and healed skin) using neonatal keratinocytes and fibroblast cells.

This technology, GRIN-SCAPE, is a high-speed microscopy approach for imaging deep 3D tissue dynamics in awake, freely behaving animals that combines Swept, Confocally-Aligned Planar Excitation (SCAPE) microscopy with a Graded-Index (GRIN) lens.

This technology is a high-throughput and scalable platform for measuring the metabolic activity of single or bulk cells in drug screening and research applications.

This technology is an automated imaging analysis platform for identifying and quantifying biomarkers that can be used to predict lung adenocarcinoma subtypes.

Thanks to the NIH R24GM153869 grant, we are pleased to provide DSSR Basic free of charge to the academic community.

This technology is patient-specific engineered model of bone marrow for diagnostics and research of cancer progression using a sample of patient’s serum.

This technology is a multiplex immunofluorescence method using beam-splitting imaging and non-specific antibodies to create a high-throughput, efficient approach for cell type identification.

This technology is a comprehensive compound design and preclinical testing platform that can be used to develop multifunctional drugs for Alzheimer’s disease, and has already led to the development of several promising lead compounds.

This technology is a platform to organize nanoscale objects into a 3D array using DNA programmable interactions, that can be used to generate 3D hierarchically ordered materials for optical and energy applications.

This technology is an in vivo system in which a covalent bond can be formed between any two proteins in a cell-type specific manner for the purpose of immunoprecipitation, visualization, or modifying the activity of a target protein.